JNJ

226.41

-0.51%↓

ABT

92.88

+1.83%↑

MDT

83.46

+0.1%↑

A

116.1

+0.6%↑

VEEV

162.02

+0.73%↑

JNJ

226.41

-0.51%↓

ABT

92.88

+1.83%↑

MDT

83.46

+0.1%↑

A

116.1

+0.6%↑

VEEV

162.02

+0.73%↑

JNJ

226.41

-0.51%↓

ABT

92.88

+1.83%↑

MDT

83.46

+0.1%↑

A

116.1

+0.6%↑

VEEV

162.02

+0.73%↑

JNJ

226.41

-0.51%↓

ABT

92.88

+1.83%↑

MDT

83.46

+0.1%↑

A

116.1

+0.6%↑

VEEV

162.02

+0.73%↑

JNJ

226.41

-0.51%↓

ABT

92.88

+1.83%↑

MDT

83.46

+0.1%↑

A

116.1

+0.6%↑

VEEV

162.02

+0.73%↑

Search

Progyny Inc

Open

BrancheGesundheitswesen

18.48 1.99

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

18

Max

18.57

Schlüsselkennzahlen

By Trading Economics

Einkommen

-1.4M

12M

Verkäufe

5.1M

318M

KGV

Branchendurchschnitt

28.677

60.328

Gewinnspanne

3.921

Angestellte

835

EBITDA

-6M

19M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+45.46% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-311M

1.5B

Vorheriger Eröffnungskurs

16.49

Vorheriger Schlusskurs

18.48

Nachrichtenstimmung

By Acuity

3%

97%

2 / 348 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Progyny Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Apr. 2026, 21:14 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26. Apr. 2026, 21:14 UTC

Wichtige Nachrichtenereignisse

Week Ahead for FX, Bonds: Major Central Bank -2-

24. Apr. 2026, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

Intertek Group Rejects EQT's Revised Offer

26. Apr. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26. Apr. 2026, 23:44 UTC

Ergebnisse

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26. Apr. 2026, 23:44 UTC

Ergebnisse

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26. Apr. 2026, 23:36 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Falls Amid Dollar's Strength -- Market Talk

26. Apr. 2026, 23:33 UTC

Market Talk
Wichtige Nachrichtenereignisse

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26. Apr. 2026, 05:12 UTC

Ergebnisse

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26. Apr. 2026, 05:12 UTC

Ergebnisse

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26. Apr. 2026, 05:12 UTC

Ergebnisse

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26. Apr. 2026, 05:12 UTC

Ergebnisse

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24. Apr. 2026, 23:37 UTC

Akquisitionen, Fusionen, Übernahmen

Scoring the Cook Era -- Barrons.com

24. Apr. 2026, 20:51 UTC

Akquisitionen, Fusionen, Übernahmen

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. Apr. 2026, 20:50 UTC

Market Talk
Wichtige Nachrichtenereignisse

Financial Services Roundup: Market Talk

24. Apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

24. Apr. 2026, 20:39 UTC

Akquisitionen, Fusionen, Übernahmen

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. Apr. 2026, 20:09 UTC

Ergebnisse

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24. Apr. 2026, 19:48 UTC

Market Talk
Wichtige Nachrichtenereignisse

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24. Apr. 2026, 19:25 UTC

Akquisitionen, Fusionen, Übernahmen

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24. Apr. 2026, 19:25 UTC

Akquisitionen, Fusionen, Übernahmen

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24. Apr. 2026, 19:22 UTC

Ergebnisse

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24. Apr. 2026, 19:06 UTC

Ergebnisse

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24. Apr. 2026, 19:05 UTC

Market Talk

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24. Apr. 2026, 18:30 UTC

Akquisitionen, Fusionen, Übernahmen

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24. Apr. 2026, 18:28 UTC

Akquisitionen, Fusionen, Übernahmen

Intertek Rejects Revised EQT Offer

24. Apr. 2026, 18:12 UTC

Market Talk

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24. Apr. 2026, 18:06 UTC

Market Talk

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24. Apr. 2026, 17:42 UTC

Ergebnisse

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24. Apr. 2026, 17:28 UTC

Ergebnisse

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Peer-Vergleich

Kursveränderung

Progyny Inc Prognose

Kursziel

By TipRanks

45.46% Vorteil

12-Monats-Prognose

Durchschnitt 26.43 USD  45.46%

Hoch 31 USD

Tief 19 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Progyny Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

7 ratings

5

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

22.91 / 23.375Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

2 / 348 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat